ConductScience.org, home
CNTN2: contactin 2
API referenceFor AI assistants

Gene · 6900

NIH grants2,058

NIH grants whose papers are about the gene, through NIH's grant-paper links.

41 to 60 of 2,058

Download this page as JSON
GrantTitleCNTN2 papersNewest fiscal year
P30EY001792P30 Core Grant for Vision Research22025
P41EB030006Center for Mesoscale Mapping22025
P50CA171963Specialized Program of Research Excellence (SPORE) in Leukemia22025
R01AI141009Role of clonal expansion in HIV-1 persistence22025
R01CA140337Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation22025
R01CA178393Genomic Architecture of LGL Leukemia22025
R01CA258359Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma22025
R01EB006841Multivariate methods for identifying multitask/multimodal brain imaging biomarkers22025
R01EY022645Gene regulation of retinal cell differentiation22025
R01NS082208Patterning dendritic branches with environmental and neuronal surface molecules22025
R37AI147868The HUSH complex in HIV-1 latency22025
T15LM009451Colorado Biomedical Informatics Training Program22025
T32AI083196Minnesota Training Program in Virology22025
T32CA113275Molecular Oncology Training Grant22025
T32GM141955Cellular, molecular, and biochemical sciences training grant22025
T32HL007088Pre-and Postgraduate Training in Molecular Hematology22025
T32MH079785Interdisciplinary And Translational Research Training In Neurohiv22025
U54GM104938Oklahoma Shared Clinical and Translational Resources22025
UL1TR001998Kentucky Center for Clinical and Translational Science22025
ZIABC006150DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6900/grants?page=3

API referenceFor AI assistants